產品介紹細胞培養與分析細胞轉染試劑與電穿孔產品TransIT®-EE

TransIT®-EE

歡迎與我們聯繫索取更多 TransIT®-EE 產品資訊與文獻。

產品效能

Fig. 1 | TransIT®-EE Solution Leads to Enhanced Luciferase Expression in the Liver. TransIT®-QR or TransIT®-EE Delivery Solutions were used to deliver 10 µg of a luciferase expression vector to mice using the hydrodynamic delivery tail vein injection procedure. Twenty-four hours post-injection the livers were harvested and assayed for luciferase activity.

 

Fig. 2 | TransIT®-EE Solution Leads to Enhanced Luciferase Expression in a Variety of Organs. TransIT®-QR or TransIT®-EE Delivery Solutions were used to deliver 10 µg of pCI-Luc (CMV promoter-driven luciferase expression vector) to mice using the hydrodynamic tail vein injection procedure. Twenty-four hours post-injection the organs were harvested and assayed for luciferase activity.
Following gene delivery via a tail vein injection, the highest level of transgene expression is found in the liver, with reduced levels of expression found in the spleen, lung, heart and kidneys.

訂購資訊

Product Name Pack Size Cat. No.
TransIT®-EE Delivery Solution 40 injections MR-MIR5340
pLIVE® Vector 20 µg MR-MIR5420
pLIVE® Vector/lacZ Control Vector Kit 20 µg of each vector MR-MIR5520
pLIVE® Vector/SEAP Control Vector Kit 20 µg of each vector MR-MIR5620
pLIVE® Vector Complete System 20 µg of each (all 3 vectors) MR-MIR5320
產品文件與相關資源